Serum CA125 elevation and risk of clinical detection of cancer in asymptomatic postmenopausal women
Open Access
- 1 May 1999
- Vol. 85 (9), 2068-2072
- https://doi.org/10.1002/(sici)1097-0142(19990501)85:9<2068::aid-cncr25>3.0.co;2-8
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Serum concentrations of cancer antigen 125, placental alkaline phosphatase, cancer-associated serum antigen and free beta human chorionic gonadotrophin as prognostic markers for epithelial ovarian cancerBJOG: An International Journal of Obstetrics and Gynaecology, 1997
- Risk of diagnosis of ovarian cancer after raised serum CA 125 concentration: a prospective cohort studyBMJ, 1996
- Defining response of ovarian carcinoma to initial chemotherapy according to serum CA 125.Journal of Clinical Oncology, 1996
- Defining progression of ovarian carcinoma during follow-up according to CA 125: A North Thames Ovary Group studyAnnals of Oncology, 1996
- Prognostic value in predicting overall survival of two mucinous markers: CA 15-3 and CA 125 in breast cancer patients at first relapse of diseaseEuropean Journal Of Cancer, 1994
- Screening for ovarian cancer. Other malignancies cloud the issue.BMJ, 1993
- Prevalence screening for ovarian cancer in postmenopausal women by CA 125 measurement and ultrasonography.BMJ, 1993
- Tribute to Patrick Steptoe: beginnings of laparoscopyHuman Reproduction, 1989
- MULTIMODAL APPROACH TO SCREENING FOR OVARIAN CANCERThe Lancet, 1988